Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Peter Maag Biography and Net Worth

Insider of CareDx

Peter Maag is the executive chairman and CEO of CareDx, a biotechnology company.

Maag first joined CareDx in 2012 as its president and CEO, a position he held until 2020. In January 2020, he was named chairman of the board, taking on the role of executive chairman in November 2020.

Prior to CareDx, Maag spent a decade with Novartis, beginning as the company’s head of strategy in 2001. During his tenure, Maag helped spearhead new ventures in the company’s molecular diagnostics, along with heading up the expansion of Novartis’ blood screening business worldwide. His most recent position with the company was as president of diagnostics from 2009 to 2012, but he also worked as Novartis’ country president in Germany and Korea.

Maag began his career in the pharmaceutical and diagnostic industry as an associate principal with McKinsey & Co from 1994 to 2001, working in Berlin and New Jersey on globalization and pharmaceutical strategies.

Maag currently serves as a board member for PHOENIX Group (Mannaheim) and MolecularMD. He studied pharmaceutical sciences at both the University of London and the University of Heidelberg and received his Ph.D. from the University of Berlin, Germany.

What is Peter Maag's net worth?: The estimated net worth of Peter Maag is at least $2.57 million as of July 13th, 2023. Dr. Maag owns 309,657 shares of CareDx stock worth more than $2,573,250 as of April 20th. This net worth approximation does not reflect any other investments that Dr. Maag may own. Additionally, Dr. Maag receives an annual salary of $43,230.00 as Insider at CareDx. Learn More about Peter Maag's net worth.
How old is Peter Maag?: Dr. Maag is currently 57 years old. There are 2 older executives and no younger executives at CareDx. Learn More on Peter Maag's age.
What is Peter Maag's salary?: As the Insider of CareDx, Inc, Dr. Maag earns $43,230.00 per year. There are 2 executives that earn more than Dr. Maag. The highest earning executive at CareDx is Mr. Alexander L. Johnson, President of Patient & Testing Services, who commands a salary of $547,430.00 per year. Learn More on Peter Maag's salary.
How do I contact Peter Maag?: The corporate mailing address for Dr. Maag and other CareDx executives is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. CareDx can also be reached via phone at (415) 287-2300 and via email at [email protected]. Learn More on Peter Maag's contact information.
Has Peter Maag been buying or selling shares of CareDx?: Peter Maag has not been actively trading shares of CareDx during the last quarter. Most recently, Peter Maag sold 5,000 shares of the business's stock in a transaction on Thursday, July 13th. The shares were sold at an average price of $10.34, for a transaction totalling $51,700.00. Following the completion of the sale, the director now directly owns 309,657 shares of the company's stock, valued at $3,201,853.38. Learn More on Peter Maag's trading history.
Who are CareDx's active insiders?: CareDx's insider roster includes Paul Adler (CEO), George Bickerstaff, III (Director), Ankur Dhingra (CFO), Michael Goldberg (Director), William Hagstrom (Director), Sasha King (CMO), Peter Maag (Insider), Reginald Seeto (Insider), Ralph Snyderman (Director), and Thomas Thomas (Director). Learn More on CareDx's active insiders.
Are insiders buying or selling shares of CareDx?: In the last twelve months, insiders at the sold shares 11 times. They sold a total of 44,448 shares worth more than $405,276.89. The most recent insider tranaction occured on October, 2nd when insider Reginald Seeto sold 2,818 shares worth more than $19,472.38. Insiders at CareDx own 4.2% of the company. Learn More about insider trades at CareDx.
Information on this page was last updated on 10/2/2023.

Peter Maag Insider Trading History at CareDx

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/13/2023	Sell	5,000	$10.34	$51,700.00	309,657
6/28/2023	Sell	2,432	$8.72	$21,207.04	313,136
2/8/2023	Sell	3,269	$15.75	$51,486.75	295,468
2/2/2023	Sell	5,000	$17.17	$85,850.00	298,737
4/5/2022	Sell	10,000	$38.64	$386,400.00	311,689
3/7/2022	Sell	10,000	$32.81	$328,100.00
2/7/2022	Sell	10,000	$42.07	$420,700.00
1/5/2022	Sell	10,000	$44.45	$444,500.00
12/6/2021	Sell	10,000	$41.62	$416,200.00
11/5/2021	Sell	10,000	$49.40	$494,000.00
10/5/2021	Sell	10,000	$64.67	$646,700.00
9/7/2021	Sell	10,000	$73.68	$736,800.00
8/5/2021	Sell	10,000	$83.13	$831,300.00	356,202
7/6/2021	Sell	10,000	$90.70	$907,000.00	374,256
6/24/2021	Sell	9,605	$95.30	$915,356.50	372,258
6/9/2021	Sell	2,522	$90.00	$226,980.00	374,466
6/7/2021	Sell	26,500	$86.25	$2,285,625.00	393,977
5/25/2021	Sell	10,000	$80.59	$805,900.00	419,444
5/10/2021	Sell	26,293	$68.94	$1,812,639.42	412,757
5/5/2021	Sell	10,000	$73.32	$733,200.00	419,444
5/3/2021	Sell	20,000	$76.64	$1,532,800.00	420,343
4/5/2021	Sell	10,000	$72.40	$724,000.00	421,468
3/5/2021	Sell	10,000	$61.29	$612,900.00
2/5/2021	Sell	10,000	$89.82	$898,200.00
1/5/2021	Sell	10,000	$71.92	$719,200.00	431,974
12/7/2020	Sell	10,000	$66.37	$663,700.00	431,974
11/5/2020	Sell	10,000	$53.48	$534,800.00	427,689
10/5/2020	Sell	10,000	$42.11	$421,100.00	431,974
9/30/2020	Sell	16,992	$37.59	$638,729.28	438,966
9/8/2020	Sell	10,000	$31.68	$316,800.00	431,974
8/5/2020	Sell	13,008	$36.77	$478,304.16	425,134
7/6/2020	Sell	10,000	$34.21	$342,100.00	421,974
6/30/2020	Sell	18,182	$35.07	$637,642.74
6/9/2020	Sell	1,818	$35.00	$63,630.00	389,499
6/5/2020	Sell	50,000	$32.58	$1,629,000.00	391,817
5/19/2020	Sell	30,000	$32.24	$967,200.00	459,909
3/16/2020	Sell	10,000	$17.39	$173,900.00	489,909
2/18/2020	Sell	10,000	$26.62	$266,200.00	451,909
1/15/2020	Sell	10,000	$23.13	$231,300.00	429,814
8/6/2019	Sell	50,000	$28.84	$1,442,000.00	379,049
5/13/2019	Sell	80,000	$31.11	$2,488,800.00	408,406
3/11/2019	Sell	50,000	$34.23	$1,711,500.00	458,406
11/29/2018	Sell	100,000	$28.53	$2,853,000.00	408,372
11/13/2018	Sell	50,000	$26.48	$1,324,000.00	389,747
9/4/2018	Sell	15,000	$23.10	$346,500.00	439,747
3/27/2018	Sell	15,000	$7.87	$118,050.00	272,037
8/15/2017	Buy	600	$1.82	$1,092.00	107,350
6/1/2015	Buy	2,000	$4.84	$9,680.00

Peter Maag Buying and Selling Activity at CareDx

CareDx Company Overview

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Today's Range

Now: $8.31

$7.98

$8.34

50 Day Range

MA: $9.67

$7.85

$12.08

2 Week Range

Now: $8.31

$4.80

$12.93

Volume

500,377 shs

Average Volume

596,666 shs

Market Capitalization

$430.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.42

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Secure Your Spot Now

Peter Maag Biography and Net Worth

What is Peter Maag's net worth?

How old is Peter Maag?

What is Peter Maag's salary?

How do I contact Peter Maag?

Has Peter Maag been buying or selling shares of CareDx?

Who are CareDx's active insiders?

Are insiders buying or selling shares of CareDx?